Valuation: DocMorris AG

Market Cap 50Cr 63Cr 54Cr 46Cr 86Cr 6TCr 87Cr 593.83Cr 231.57Cr 3.01TCr 235.47Cr 230.34Cr 9.97TCr P/E 2026 *
-6.14x
P/E 2027 * -13x
Enterprise Value 70Cr 88Cr 75Cr 64Cr 121.05Cr 8.41TCr 122.65Cr 832.49Cr 324.64Cr 4.23TCr 330.1Cr 322.92Cr 14TCr EV / Sales 2026 *
0.56x
EV / Sales 2027 * 0.52x
Free-Float
65.15%
Yield 2026 *
-
Yield 2027 * -
1 year 7.45
Extreme 7.454
7.45
3 years 7.45
Extreme 7.454
108.05
5 years 7.45
Extreme 7.454
425
10 years 7.45
Extreme 7.454
547
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2022
Director of Finance/CFO 56 01/10/2024
Chief Tech/Sci/R&D Officer - 01/11/2024
Director TitleAgeSince
Chairman 68 28/04/2022
Director/Board Member 53 23/05/2019
Director/Board Member 56 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
-27.18%-.--% - - 63Cr
+1.63%-2.13%-40.02%-6.39% 1.57TCr
0.00%+0.46%-40.83%-23.83% 672.16Cr
+0.49%+2.25%-18.13%-12.75% 636.44Cr
-0.83%-0.42%-2.29%-23.01% 431.58Cr
+0.65%-1.99%-18.04%-38.82% 324.06Cr
+2.09%-0.75%-45.36%-24.10% 305.11Cr
-2.91%-1.40%+2.26%-36.86% 299.18Cr
-1.97%-3.96%-15.32%-7.12% 255.16Cr
+1.20%-1.30%+44.28% - 240.26Cr
Average -2.68%-0.87%-14.83%-21.61% 526.3Cr
Weighted average by Cap. +0.12%-0.84%-24.32%-17.10%

Financials

2026 *2027 *
Net sales 124.86Cr 155.78Cr 133.44Cr 114.29Cr 214.49Cr 15TCr 217.32Cr 1.48TCr 575.25Cr 7.49TCr 584.93Cr 572.2Cr 25TCr 140.83Cr 175.7Cr 150.51Cr 128.91Cr 241.93Cr 17TCr 245.12Cr 1.66TCr 648.84Cr 8.45TCr 659.75Cr 645.4Cr 28TCr
Net income -8.6Cr -11Cr -9.19Cr -7.87Cr -15Cr -1.03TCr -15Cr -101.62Cr -40Cr -515.8Cr -40Cr -39Cr -1.71TCr -4.26Cr -5.31Cr -4.55Cr -3.9Cr -7.32Cr -508.5Cr -7.41Cr -50Cr -20Cr -255.44Cr -20Cr -20Cr -844.9Cr
Net Debt 20Cr 25Cr 22Cr 18Cr 35Cr 2.41TCr 35Cr 238.66Cr 93Cr 1.21TCr 95Cr 93Cr 4.01TCr 23Cr 29Cr 25Cr 21Cr 40Cr 2.79TCr 41Cr 276.49Cr 107.82Cr 1.4TCr 109.64Cr 107.25Cr 4.64TCr
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
1,337
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
9.955CHF
Average target price
10.92CHF
Spread / Average Target
+9.68%

Quarterly revenue - Rate of surprise